Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Integrative genomics identifies RAB23 as an invasion mediator gene in diffuse-type gastric cancer.

Hou Q, Wu YH, Grabsch H, Zhu Y, Leong SH, Ganesan K, Cross D, Tan LK, Tao J, Gopalakrishnan V, Tang BL, Kon OL, Tan P.

Cancer Res. 2008 Jun 15;68(12):4623-30. doi: 10.1158/0008-5472.CAN-07-5870.

2.

Reduced expression and homozygous deletion of annexin A10 in gastric carcinoma.

Kim J, Kim MA, Jee CD, Jung EJ, Kim WH.

Int J Cancer. 2009 Oct 15;125(8):1842-50. doi: 10.1002/ijc.24541.

3.

Krüppel-like factor 12 plays a significant role in poorly differentiated gastric cancer progression.

Nakamura Y, Migita T, Hosoda F, Okada N, Gotoh M, Arai Y, Fukushima M, Ohki M, Miyata S, Takeuchi K, Imoto I, Katai H, Yamaguchi T, Inazawa J, Hirohashi S, Ishikawa Y, Shibata T.

Int J Cancer. 2009 Oct 15;125(8):1859-67. doi: 10.1002/ijc.24538.

4.

The microRNA-367 inhibits the invasion and metastasis of gastric cancer by directly repressing Rab23.

Bin Z, Dedong H, Xiangjie F, Hongwei X, Qinghui Y.

Genet Test Mol Biomarkers. 2015 Feb;19(2):69-74. doi: 10.1089/gtmb.2014.0210. Epub 2014 Dec 9.

PMID:
25489984
5.

Novel regions of chromosomal amplification at 6p21, 5p13, and 12q14 in gastric cancer identified by array comparative genomic hybridization.

Gorringe KL, Boussioutas A, Bowtell DD; Melbourne Gastric Cancer Group, Peter Mac Micro Array Facility.

Genes Chromosomes Cancer. 2005 Mar;42(3):247-59.

PMID:
15611932
6.

Identification of CCND3 and BYSL as candidate targets for the 6p21 amplification in diffuse large B-cell lymphoma.

Kasugai Y, Tagawa H, Kameoka Y, Morishima Y, Nakamura S, Seto M.

Clin Cancer Res. 2005 Dec 1;11(23):8265-72.

7.

Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma.

Nishimura Y, Komatsu S, Ichikawa D, Nagata H, Hirajima S, Takeshita H, Kawaguchi T, Arita T, Konishi H, Kashimoto K, Shiozaki A, Fujiwara H, Okamoto K, Tsuda H, Otsuji E.

Br J Cancer. 2013 Apr 2;108(6):1324-31. doi: 10.1038/bjc.2013.65. Epub 2013 Feb 19.

8.

Inactivation of Rab23 inhibits the invasion and motility of pancreatic duct adenocarcinoma.

Cai ZZ, Xu LB, Cai JL, Wang JS, Zhou B, Hu H.

Genet Mol Res. 2015 Mar 30;14(1):2707-15. doi: 10.4238/2015.March.30.31.

9.

Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high-resolution microarray comparative genomic hybridization.

Weiss MM, Snijders AM, Kuipers EJ, Ylstra B, Pinkel D, Meuwissen SG, van Diest PJ, Albertson DG, Meijer GA.

J Pathol. 2003 Jul;200(3):320-6.

PMID:
12845628
10.

Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach.

Li R, Wang H, Bekele BN, Yin Z, Caraway NP, Katz RL, Stass SA, Jiang F.

Oncogene. 2006 Apr 27;25(18):2628-35.

PMID:
16369491
11.

Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma.

Patil MA, Gütgemann I, Zhang J, Ho C, Cheung ST, Ginzinger D, Li R, Dykema KJ, So S, Fan ST, Kakar S, Furge KA, Büttner R, Chen X.

Carcinogenesis. 2005 Dec;26(12):2050-7. Epub 2005 Jul 6.

PMID:
16000397
12.

Metastasis-associated long non-coding RNA drives gastric cancer development and promotes peritoneal metastasis.

Okugawa Y, Toiyama Y, Hur K, Toden S, Saigusa S, Tanaka K, Inoue Y, Mohri Y, Kusunoki M, Boland CR, Goel A.

Carcinogenesis. 2014 Dec;35(12):2731-9. doi: 10.1093/carcin/bgu200. Epub 2014 Oct 3.

13.

Rab23 is overexpressed in human bladder cancer and promotes cancer cell proliferation and invasion.

Jiang Y, Han Y, Sun C, Han C, Han N, Zhi W, Qiao Q.

Tumour Biol. 2016 Jun;37(6):8131-8. doi: 10.1007/s13277-015-4590-9. Epub 2015 Dec 29.

PMID:
26715272
14.

Comprehensive analysis of 19q12 amplicon in human gastric cancers.

Leung SY, Ho C, Tu IP, Li R, So S, Chu KM, Yuen ST, Chen X.

Mod Pathol. 2006 Jun;19(6):854-63.

15.

Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression.

Anders M, Vieth M, Röcken C, Ebert M, Pross M, Gretschel S, Schlag PM, Wiedenmann B, Kemmner W, Höcker M.

Br J Cancer. 2009 Jan 27;100(2):352-9. doi: 10.1038/sj.bjc.6604876. Epub 2009 Jan 13.

16.

High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.

Wang Z, Cai SR, He YL, Zhan WH, Chen CQ, Cui J, Wu WH, Wu H, Song W, Zhang CH, Peng JJ, Huang XH.

Ann Surg Oncol. 2009 Jan;16(1):208-19. doi: 10.1245/s10434-008-0214-6. Epub 2008 Nov 14.

PMID:
19009246
17.

Rab40b upregulation correlates with the prognosis of gastric cancer by promoting migration, invasion, and metastasis.

Li Y, Jia Q, Wang Y, Li F, Jia Z, Wan Y.

Med Oncol. 2015 Apr;32(4):126. doi: 10.1007/s12032-015-0562-6. Epub 2015 Mar 20.

PMID:
25790780
18.

A functional and transcriptomic analysis of NET1 bioactivity in gastric cancer.

Bennett G, Sadlier D, Doran PP, Macmathuna P, Murray DW.

BMC Cancer. 2011 Feb 1;11:50. doi: 10.1186/1471-2407-11-50.

19.

JAM-A expression positively correlates with poor prognosis in breast cancer patients.

McSherry EA, McGee SF, Jirstrom K, Doyle EM, Brennan DJ, Landberg G, Dervan PA, Hopkins AM, Gallagher WM.

Int J Cancer. 2009 Sep 15;125(6):1343-51. doi: 10.1002/ijc.24498.

20.

Identification of IL11RA and MELK amplification in gastric cancer by comprehensive genomic profiling of gastric cancer cell lines.

Calcagno DQ, Takeno SS, Gigek CO, Leal MF, Wisnieski F, Chen ES, Araújo TM, Lima EM, Melaragno MI, Demachki S, Assumpção PP, Burbano RR, Smith MC.

World J Gastroenterol. 2016 Nov 21;22(43):9506-9514.

Supplemental Content

Support Center